Privi Speciality Chemicals Limited (NSE:PRIVISCL)
India · Delayed Price · Currency is INR | Market Cap | 129.66B +65.4% |
| Revenue (ttm) | 25.64B +22.0% |
| Net Income | 3.28B +75.2% |
| EPS | 83.85 +75.2% |
| Shares Out | n/a |
| PE Ratio | 39.59 |
| Forward PE | 32.96 |
| Dividend | 10.00 (0.32%) |
| Ex-Dividend Date | Jul 31, 2026 |
| Volume | 60,691 |
| Average Volume | 122,606 |
| Open | 3,303.30 |
| Previous Close | 3,267.30 |
| Day's Range | 3,283.80 - 3,345.50 |
| 52-Week Range | 2,050.00 - 3,590.90 |
| Beta | -0.07 |
| RSI | 59.31 |
| Earnings Date | May 11, 2026 |
About NSE:PRIVISCL
Privi Speciality Chemicals Limited engages in the manufacture, supply, and export of aroma and fragrance chemicals in India, North America, Asia, the Middle East, Africa, Europe, South America, and the United Kingdom. It offers a range of aroma chemicals, including alpha damascone, alpha ionone, alpha terpenyl acetate, amber fleur, amber gamma, beta iso damascol, BI perfumery grade, BI technical grade, carene-60 and carene-90, carvacrol, cedar ketol, citronellal, citronellol, citronellyl acetate, citronellyl nitrile, dipentene, double distilled... [Read more]
Financial Performance
In fiscal year 2026, NSE:PRIVISCL's revenue was 25.64 billion, an increase of 22.01% compared to the previous year's 21.01 billion. Earnings were 3.28 billion, an increase of 75.16%.
Financial StatementsNews
Privi Speciality Chemicals Transcript: Q4 25/26
FY 2025-26 saw 21.7% revenue and 75% PAT growth, with EBITDA margins above 25% and strong cash flow. Capacity expansions, new specialty products, and a successful JV underpin a 20% growth outlook and robust industry demand.
Privi Speciality Chemicals Transcript: Q4 25/26
Revenue grew 21.7% and EBITDA 40.4% YoY in FY 2025-26, with margins at 25.8% and PAT up 75%. Capacity expansions, new specialty products, and a profitable JV drive a strong outlook, targeting 20% growth and sustained margins.
Privi Speciality Chemicals Quarterly report: Q4 2026
Privi Speciality Chemicals has published its Q4 2026 quarterly earnings report on May 12, 2026.
Privi Speciality Chemicals Slides: Q4 2026
Privi Speciality Chemicals has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 12, 2026.
Privi Speciality Chemicals Transcript: Q3 25/26
Reported 24% YoY revenue growth and 25%+ EBITDA margins for Q3 and nine months, with strong operational efficiency and robust export demand. Capacity expansion and new product launches are on track, targeting INR 5,000 crore revenue and INR 1,000 crore EBITDA in 3-4 years.
Privi Speciality Chemicals Transcript: Q3 25/26
Reported 24% YoY revenue growth and 25%+ EBITDA margins for Q3 and nine months, with strong operational efficiency and robust export demand. Capacity expansion and new product launches are on track, targeting INR 5,000 crore revenue and INR 1,000 crore EBITDA in 3-4 years.
Privi Speciality Chemicals Quarterly report: Q3 2026
Privi Speciality Chemicals has published its Q3 2026 quarterly earnings report on February 10, 2026.
Privi Speciality Chemicals Slides: Q3 2026
Privi Speciality Chemicals has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 10, 2026.
Privi Speciality Chemicals Transcript: Q2 25/26
Record Q2 and H1 FY2026 results with 26% YoY revenue and 59% YoY EBITDA growth, driven by volume and new products. Capacity expansion, robust demand, and state incentives support a strong outlook, with a 3-4 year target of doubling revenue and EBITDA.
Privi Speciality Chemicals Transcript: Q2 25/26
Record Q2 and H1 FY2026 results with 26% YoY revenue and 59% YoY EBITDA growth, driven by volume and new products. Capacity expansion, robust demand, and state incentives support a strong outlook, with a 3-4 year target of doubling revenue and EBITDA.
Privi Speciality Chemicals Quarterly report: Q2 2026
Privi Speciality Chemicals has published its Q2 2026 quarterly earnings report on November 7, 2025.
Privi Speciality Chemicals Slides: Q2 2026
Privi Speciality Chemicals has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 7, 2025.
Privi Speciality Chemicals Transcript: Q1 25/26
Q1 FY26 saw 22% revenue growth and 45% EBITDA growth, with margins at 24.8%. Capacity expansions, strong ESG performance, and a merger are set to drive 20% annual growth and INR 5,000 crore revenue in 3–5 years. Gross margins and efficiency gains remain robust.
Privi Speciality Chemicals Transcript: Q1 25/26
Q1 FY26 saw 22% revenue growth and 45% EBITDA growth, with margins at 24.8%. Capacity expansions, strong ESG performance, and a merger are set to drive 20% annual growth and INR 5,000 crore revenue in 3–5 years. Gross margins and efficiency gains remain robust.
Privi Speciality Chemicals Quarterly report: Q1 2026
Privi Speciality Chemicals has published its Q1 2026 quarterly earnings report on August 5, 2025.
Privi Speciality Chemicals Slides: Q1 2026
Privi Speciality Chemicals has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on August 5, 2025.
Privi Speciality Chemicals Transcript: Q4 24/25
Record FY25 results with 19% revenue and 37% EBITDA growth, driven by process improvements, new products, and strong export demand. Margins are expected to remain above 20% as capacity expands and value-added products increase. CapEx of INR 250-300 crore planned for further growth.
Privi Speciality Chemicals Transcript: Q4 24/25
Record FY25 results with 19% revenue and 37% EBITDA growth, driven by process improvements, new products, and strong export demand. Margins are expected to remain above 20% as capacity expands and value-added products increase. CapEx of INR 250-300 crore planned for further growth.
Privi Speciality Chemicals Annual report: Q4 2025
Privi Speciality Chemicals has published its Q4 2025 annual report on May 6, 2025.
Privi Speciality Chemicals Quarterly report: Q4 2025
Privi Speciality Chemicals has published its Q4 2025 quarterly earnings report on May 6, 2025.
Privi Speciality Chemicals Slides: Q4 2025
Privi Speciality Chemicals has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on May 6, 2025.
Privi Speciality Chemicals Transcript: Q3 24/25
Q3 and nine-month results showed strong revenue and margin growth, driven by capacity expansion, improved product mix, and process efficiencies. A robust order book, price increases, and ongoing capex support a positive outlook, with 20% revenue growth targeted for FY26.
Privi Speciality Chemicals Transcript: Q3 24/25
Q3 and nine-month results showed strong revenue and margin growth, driven by capacity expansion, improved product mix, and process efficiencies. A robust order book, price increases, and ongoing capex support a positive outlook, with 20% revenue growth targeted for FY26.
Privi Speciality Chemicals Quarterly report: Q3 2025
Privi Speciality Chemicals has published its Q3 2025 quarterly earnings report on February 13, 2025.
Privi Speciality Chemicals Slides: Q3 2025
Privi Speciality Chemicals has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on February 13, 2025.